Fabio Benedetti;Jennifer Smith;Calvin B. Harley;Laurence Elias;Mark J. Ratain
发明人:
Calvin B. Harley,Laurence Elias,Jennifer Smith,Mark J. Ratain,Fabio Benedetti
申请号：
US13124376
公开号：
US08877723B2
申请日:
2009.10.13
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The invention provides methods for determining the susceptibility of cancer patients to developing adverse reactions if treated with a telomerase inhibitor drug by measurement of telomere length in appropriate cells of the patient prior to initiation of the telomerase inhibitor treatment.
